Recent US data showed a reduction in lymphocyte-depleting agent in the COVID-19 era and an increasing trend in IL-2 blockers [21] .
← all excerpts
Is Early COVID-19 in Kidney Transplant Recipients Concerning Enough to Halt Transplantation? A Multicenter Comparative Analysis from India.
1
—
—